Summary & Overview
HCPCS S0039: Sulfamethoxazole-Trimethoprim Injection, 10 ml
HCPCS Level II code S0039 represents an injectable formulation of sulfamethoxazole and trimethoprim supplied as a 10 ml unit. This code matters nationally as it identifies a specific parenteral antibiotic product used in outpatient and clinic settings where injectable antimicrobials are provided. Precise coding for injectable antibiotics affects billing accuracy, inventory management, and clinical documentation for infusions and urgent care administrations.
Key payers examined include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for injectable sulfamethoxazole-trimethoprim, typical sites of service, and the scope of billing considerations tied to this HCPCS Level II code. The publication also outlines expected benchmarks and policy considerations relevant to payers nationally, and highlights areas where further documentation or coding specificity is commonly required.
The article is organized to help billing managers, clinicians, and policy analysts quickly locate benchmark information, payer coverage notes, and clinical use context for S0039. Data not available in the input will be flagged where applicable.
Billing Code Overview
HCPCS Level II code S0039 denotes an injection formulation of sulfamethoxazole and trimethoprim supplied in a 10 ml quantity. The service type is an antibiotic injection administration/product intended for parenteral antimicrobial therapy. The typical site of service for this product is outpatient infusion or clinic-based injectable administration, including ambulatory clinics and emergency department settings where injectable antibiotics are supplied or administered.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an outpatient infusion center or emergency department with a documented bacterial infection for which oral trimethoprim–sulfamethoxazole is not feasible (for example, vomiting, malabsorption, or intolerance) or when a parenteral dose is clinically indicated. Example scenario: a 58-year-old male with a soft-tissue abscess and swallowing dysfunction receives a single monitored intramuscular or intravenous injection of S0039 (injection, sulfamethoxazole and trimethoprim, 10 ml) after evaluation by a physician or advanced practice clinician. The clinical workflow includes assessment and documentation of the indication (site and severity of infection), allergy review, informed consent when applicable, vital signs and monitoring during and after administration, medication preparation by nursing or pharmacy, administration with appropriate route documentation (IM or IV), and post-administration documentation of response and any adverse events. Usual sites of service are hospital outpatient departments, emergency departments, ambulatory infusion centers, and skilled nursing facilities where parenteral antibiotic administration is provided.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural service | Use when administration required substantially greater resources than usual (extensive monitoring, complicated preparation) and documentation supports increased work |